Douglas Cole

Douglas Cole

Founder chez FOGHORN THERAPEUTICS INC.

Fortune : 525 436 $ au 31/07/2023

63 ans
Health Technology
Commercial Services
Consumer Services

Profil

Douglas G.
Cole
founded 7 companies, among them: Moderna, Inc., Foghorn Therapeutics, Inc. and Syros Pharmaceuticals, Inc. Presently, he holds the position of Chairman for Foghorn Therapeutics, Inc. (which he founded in 2015), Chairman for Repertoire Immune Medicines, Inc. and Managing Partner at Flagship Pioneering.
Dr. Cole is also Member of The Phi Beta Kappa Society and on the board of 8 other companies.
Douglas G.
Cole
previously was Director at Sigilon Therapeutics, Inc. (he founded the company in 2015), Program Executive at Vertex Pharmaceuticals, Inc., Principal at Selventa, Inc., Medical Director for CytoTherapuetics, Inc., Principal at Renovis, Inc., Principal at Hypnion, Inc., Member of Alpha Omega Alpha Honor Medical Society, Director at Ensemble Therapeutics Corp., Director at Permeon Biologics, Inc., Director at Syros Pharmaceuticals, Inc. and Director at Moderna, Inc. Douglas G.
Cole
received an undergraduate degree from Dartmouth College and a doctorate from Perelman School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/06/2023 26 564 ( 0,02% ) 525 436 $ 29/02/2024
11/08/2023 0 ( -.--% ) - $ 31/07/2023
21/06/2023 0 ( -.--% ) - $ 29/02/2024
03/04/2023 0 ( -.--% ) - $ 29/02/2024

Postes actifs de Douglas Cole

SociétésPosteDébut
FOGHORN THERAPEUTICS INC. Founder 01/10/2015
SANA BIOTECHNOLOGY, INC. Director/Board Member 01/04/2020
Private Equity Investor 01/01/2001
Birch Rock Camp Director/Board Member -
Director/Board Member -
Director/Board Member 01/08/2015
Director/Board Member -
Chairman -
Director/Board Member -
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tous les postes actifs de Douglas Cole

Anciens postes connus de Douglas Cole

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Douglas Cole

Formation de Douglas Cole

Dartmouth College Undergraduate Degree
Perelman School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Cole

Relations

100 +

Relations au 1er degré

44

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées10
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

QUANTERIX CORPORATION

Health Technology

AGIOS PHARMACEUTICALS, INC.

Health Technology

SYROS PHARMACEUTICALS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

DENALI THERAPEUTICS INC.

Health Technology

SIGILON THERAPEUTICS, INC.

Health Technology

FOGHORN THERAPEUTICS INC.

Health Technology

MODERNA, INC.

Health Technology

SANA BIOTECHNOLOGY, INC.

Health Technology

Entreprise privées32

Health Technology

Commercial Services

Commercial Services

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Finance

CytoTherapuetics, Inc.

Finance

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Birch Rock Camp

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Cole